13F-HR filed by Ghost Tree Capital, LLC
Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 35 holding rows worth $234,221,000.
- Accession
- 0001420506-23-000502
- Filer
- CIK 1595851
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 35 entries on the cover page, a total value of $234,221,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $234,221,000 with VALUE read as dollars as filed, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 500,000 | $18,995,000 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 235,000 | $18,126,000 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 130,000 | $15,877,000 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 300,000 | $15,513,000 | dollars as filed | |
| INVESCO QQQ TR | 46090E103 | COM | 50,000 | $13,314,000 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 350,000 | $12,933,000 | dollars as filed | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 1,850,000 | $11,119,000 | dollars as filed | |
| SEAGEN INC | 81181C104 | COM | 85,000 | $10,923,000 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 450,000 | $9,635,000 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 800,000 | $9,248,000 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 200,000 | $9,062,000 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 1,300,000 | $8,307,000 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 40,000 | $7,860,000 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 160,000 | $7,672,000 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 55,000 | $7,127,000 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 450,000 | $6,701,000 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 20,000 | $5,805,000 | dollars as filed | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 300,000 | $5,538,000 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 165,000 | $4,820,000 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 85,000 | $4,658,000 | dollars as filed | |
| PROVENTION BIO INC | 74374N102 | COM | 400,000 | $4,228,000 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 135,000 | $3,956,000 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 150,000 | $3,818,000 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 300,000 | $2,820,000 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 225,000 | $2,583,000 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 125,000 | $2,475,000 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 339,907 | $2,393,000 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 100,000 | $2,219,000 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 80,000 | $1,173,000 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 90,000 | $1,155,000 | dollars as filed | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 9,896 | $1,089,000 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 1,000,000 | $993,000 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 20,000 | $876,000 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 82,853 | $850,000 | dollars as filed | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 800,000 | $360,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-23-000502 | this filing | 2023-02-14 | acceptance time not in the bulk data set |